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In normal human epidermis, expression of HLA-DR 
antigen is restricted to Langerhans cells (LC) and acro-
syringial epithelium. However, in diseases such as lichen 
planus and graft-vs.-host, HLA-DR antigen appears to 
be expressed by keratinocytes, although the exact source 
of the HLA-DR is unclear. Two possibilities are that (1) 
the HLA-DR is shed by neighboring immunocompetent 
cells, or (2) that the keratinocytes are synthesizing the 
antigen themselves, Recently, gamma interferon has 
been shown to induce HLA-DR biosynthesis and expres-
sion on human malignant melanoma cells lines and on 
normal vascular endothelium. We report here that pure 
recombinant human gamma interferon (100 units/ml) 
induces HLA-DR expression on 60-70% of cultured hu-
man adult keratinocytes depleted of LC within 2- 4 days 
of culture as determined by fluorescence-activated cell 
sorter (F ACS) analysis using monoclonal antibodies. No 
residual LC or lymphocytes could be detected in these 
cultures. This is the first demonstration of HLA-DR 
expression by cultured human keratinocytes. This 
expression may be of functional significance in antigen 
presentation and cell-mediated cytotoxicity involving 
the epidermis. 
Expression of the class II major histocompatibility complex 
antigen (HLA-DR) is required for antigen presentation [1] and 
induction of cytolytic T lymphocytes [2] . In normal human 
epidermis HLA-DR is expressed only on Langherhans cells 
(LC) [3] and acrosyringial epithelium [4] . The dendritic LC is 
thought to function as the primary antigen-presenting cell in 
the epidermis. However, keratinocytes express HLA-DR in a 
wide variety of diseases which include allergic contact derma-
titis [5], lichen planus [6], and graft-vs.-host disease [7] . The 
dermis in these diseases contains a relatively dense, predomi-
nantly T-Iymphocyte infiltrate. It is not known whether the 
HLA-DR is a product of these immunocompetent cells or the 
keratinocytes themselves. 
Frozen sections from herpes labialis lesions demonstrate that 
within 2 days of recurrence, the entire epidermal layer sta ins 
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Abbreviations: 
DPBS: Dulbecco's phosphate-buffered saline 
FACS: fluorescence-activated cell sorter 
FCS: fetal ca lf serum 
FITC: fluorescein isothiocyanate-conjugated 
HLA: class II major histocompatibility complex antigen 
LC: Langerhans cell(s) 
r-1FN-,,: recombinant gamma interferon 
positive for HLA-DR and infiltrating lymp hoid cells are posi-
tive for gamma interferon (T. Cunningham, personal commu-
nication). Gamma interferon, which is produced by T lympho-
cytes [8] has recently been shown to induce HLA-DR biosyn-
thesis and expression on human malignant melanoma lines [9] 
and cu ltured human vascu lar endothelium [10]. These findings 
suggested to us that gamma interferon, which has been shown 
to be a powerful, immune regulator as well as an antiviral and 
antiproliferative agent, may be capable of inducing HLA-DR 
expression on normal adu lt keratinocytes. We report here that 
recombinant gamma interferon (r-IFN-I') induces HLA-DR 
expression on cultured human adult keratinocytes depleted of 
LC. The HLA-DR expression by keratinocytes may function-
ally increase the antigen-p resenting capacity of the epidermis 
in allergic contact dermatitis or signal keratinocyte destruction 
by T lymphocytes as seen in lichen planus and graft-vs.-host 
disease. 
MATERIALS AND METHODS 
Interferon 
Human r-IFN-" from Escherichia coli was generously supplied by 
Dr. G. Burton (Genentech, San Francisco, Californ ia). The titer of the 
r-IFN -" as determined by virus inhibition plaque assay was 5 x 107 
reference units/ml (U/ml) and the specific activity was 1 X 107 ~U/mg. 
Preparation of Dispersed Shin Cells 
Single cell suspensions of normal skin were prepared from facial 
skin obtained at surl'ery [11] . Trimmed skin was cut into 1 X 5 em --
strips and split-cut wit h a Castroviejo keratotome set at 0.1 mm. The 
resulting slices were t reated for 25 min at 37· C with 0.3% trypsio plus 
0.1 % EDTA in GNK (0.8% NaCI, 0.04 % KCI, 0.1 % g.lucose, 0.084 % \. 
NaHCO~, pH 7.3) . Dispersed cells were suspended in Dulbecco's mod-
ified Eagle's medium supplemented with 10% hea t- inacti~ated fe ta l 
calf serum (FCS) , 50 Ilg/m l gentamicin, and 2 mM L-glutamine (com-
plete medium). Viability, as determined by trypan blue exclusion im -
mediately after trypsinization, was 90% or better. Small, round viable 
cells (2 X 10(;) were seeded on 3.5 cm collagen-coated Petri dishes (Lux, 
Flow Lab) in complete medium Ill]. The cells were mainta ined in a 
humidified incubator with 5% CO,/95% ai r at 37· C [l1J . For all 
experiments, r-IFN-" was added at 48 h after cell seeding. All t ime 
points indicated for harvesti ng and staining of cu ltures refer to this 
time point as day o. 
Panning 
A 100 X 25 mm Lab Tek Petri dish (Scientific Products ) was coated 
with goat anti mouse immunoglobulin (Tago, Inc., Burlingame, Califor-
nia) at 10 Ilg/ml in 0.05 M Tris buffer, pH 9.5, incubated for 40 min at 
room temperature and then washed 3 t imes wit h Dulbecco's phosphate-
buffered saline (DPBS) and once with 5% FCS/ PBS [12]. The epider-
mal cells were incubated with antibody OKT6 (O rtho Diagnostic Sys· 
tems) for 20 min, washed, resuspended in 5% FCS/PBS, layered on 
the coated Petri dish surface, incubated at 4·C for 40 min, swirled, and 
incubated for another 30 min. The supernatant conta ining unattached 
cells was poured off gently, and the Petri di sh surface washed once 
with 1 % FeS/PBS. The cells in t he first wash were pooted with the 
supernatant cells and seeded exactly as described above. 
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Fluorescein Labeling and FA CS Analysis 
The cultured cells were washed to remove nonattached cells and the 
monolayer was t rypsinized for 10 min using O.~% trypsin plus 1% 
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E DTA a nd washed with DPES co ntaining Ca"' a nd Mgt+. Aliquots of 
5 X 10" to 10" viable ce lls were indirectly sta ined fo r 20 min on ice with 
1 jl.g of a nti- H LA -DR monoclona l a ntibody L243 (l gG 2. ) (Becton 
Dickinson Monoc lonal Ce nter, Inc. , Moun ta in View, Cali fo rnia) a nd 
0.5 jl. g of OKT6 (l gG I ) diluted in heat-in act.ivated FCS conta ining 0.1 % 
so di um azide. Nonspec ific a nd Fc recepto r-mediated background stain -
ing was dete rmi ned either by omi tting fi rst-step ant ibody, L243 or 
O KT6, or substitut ing control isotypes for the first step. The cells were 
t h e n was hed twice wit h DPBS and sta ined for 20 min wi th 1 !1 g 
flu o rescein isothiocya nate-conjugated (FITC) goat an t imouse IgG mon-
oclo na l a nt ibody (Becton-Dickinso n, Moun ta in View, Cali fo rnia). The 
labeled cells we re dilu ted wi t h DPBS a nd cent rifuged through a layer 
of heat- inactivated FCS. T he cells were then washed wit h DPBS a nd 
fixed wi th 1 % paraformaldehyde in PBS. The fluorescence per cell was 
determined wi t h a flu orescence-activated cell sorter (FACS Ill; Bect on-
D ic kin son), a nd a histogram showing t he number of stain ed cells 
against t he in tensity of fluo rescence was recorded. . . 
In s itu immunofluorescence was accomplished followmg the above 
p r ocedure, omitting t he trypsinization. Coverslips were placed over the 
ceUs attached to t.he culture dishes a nd t he cul tures were photographed 
w it h a Leitz Dialux-20 microscope. 
RESULTS 
Primary cultures of keratinocytes from 3 different adult 
p atients were treated with r-IFN-I' (100 vim!) 48 h after 
s ee ding. The cul tures were trypsinized and stained wi th a 
monoclonal antibody against HLA-DR. These cells were ana-
ly zed for both mean expression of HLA-DR per cell and the 
percent of posi t ive cells per cult ure (Table 0. R-IFN --y en-
h a nced t he mean expression of HLA-DR (70- 130) and in-
c re a sed the percent of cell s stained to 50- 70% by day 4 as seen 
in t he hi stogram and the FACS analysis (Fig 1) . We have found 
t h at this staining on day 4 represents near maximal HLA-DR 
expression by cul tured keratinocytes. 
To eliminate the possible shedding of HLA-DR from LC and 
s ubsequent adsorpt ion by keratinocytes, cell suspensions were 
depleted of LC by panning prior to seeding. We have previously 
demonstrated t hat LC-depleted kera t inocytes contain fewer 
t h a n 1% LC [12]. On day 4, t hese cultures were stained and 
a nalyzed for OKT6 express ion. No significant residual OKT6-
positive cells could be detected at t hat time (Table I). Enhance-
T A BLE l. Effect of recombinant gamma interferon on cultured human 
kera tinocy te HLA- DR expression 
A. Keratinocyte cultures· 
HLA -DR stain ing 
Experiment. 
Meanb % Swined' 
\ . 1 Expenment 
Control 0.5 0 
Gamma interferon t reated" 130.0 72.0 
E xperiment 2 
Control 0 0 
Ga mma interferon trea ted 68.0 64.0 
E xperiment 3 
Control 0 0 
Gamma in te1lfe ron t reated 84.0 54 .0 
B. LC-depleted kera tinocy te cultures· 
HLA -DR and OKT -6 stain ing 
Experilne nt 
Menn° % Swined' 
HLA-DR 
Control 1.0 1.0 
Gamma interferon treated 89.0 50.0 
OKT6 
Control 0 0 
Gamma interferon treated 5.0 0 
a Nonspecific and Fc receptor-mediated background staining has 
bee n subt racted. 
b.< Mean expression of fluorescence per ce ll and percent of cells with 
detectable sta ining were a nalyzed by FACS on setting: fluorescence = 
2, scatte r = 1, photomultipl ie r tube 650. 
d 100 uni ts/m!. 
ment of HLA-DR expression was similar to that seen IJ1 t he 
undepleted ke ratinocyte cul tu res (Table 0. 
Neither LC depletion nor r- IFN--y resul ted in gross morpho-
logic changes in t he attached keratinocyte monolayers (Fig 2a). 
These cul tured ce ll s a re hexagona l wi th round nuclei and 
prominent nucleoli , typical of cultured keratinocytes. Since 
rounded-up cluste rs of keratinocytes occasiona lly remained 
attached to t he underlying monolaye r, we performed in s it.u 
staining. Fig 2b shows the immunoflu orescence HLA-DR sta in -
ing pattern observed on a day-4 LC-depleted cul tu re with a 
phase microscopic view of the ident ical fi eld (Fig 2c). T his 
in te nse, rather uniform cell surface flu orescence of the hexag-
onal, attached cell s characterized the majori ty of H LA-DR-
posit ive keratinocytes. The r-IFN --y-treated cul tures stained in 
situ on day 4 with goat ant imouse IgG-FITC alone as a cont rol 
showed no specific flu orescence. 
DISCUSSION 
This is t he first demonstration of HLA-DR expression by 
cul tured human keratinocytes. Normal cul tured epidermal cells 
do not synthes ize H LA-DR after 7 days in cul ture, which 
presumably refl ects t he lack of growth of LC and acrosy ringium 
in t he cul ture dishes [13]. In order to eliminate t he possible 
shedding of HLA-DR by LC and adsorption by ke ratinocytes 
in r-IFN-I'-treated ea rly cul tures, we selective ly removed LC 
by a panning technique ut ilizing ant ibody OKT6. This panning 
tec hnique has previously been shown to reduce t he num ber of 
LC, which normally cont ribute 2-6% of t he total population of 
epidermal ce ll s, to less t han 1 % [12J. These cul tures no longe r 
contain LC as defin ed by monoclonal ant ibody staining and 
FACS analysis (T able 0. Our data indicate t hat t hese cu ltured 
keratinocytes are synthesizing and exp ressing HLA-DR and 
not adsorbing shed ant igens. However, we plan to measure 
direct biosynthesis of HLA-DR by these cells using [:I"SJmethi -
onine labeled ext racts and polyac rylamide ge l electrophoresis. 
Our resul ts are consistent with previous reports t hat r-IFN-
I' induced expression of HLA-DR in human melanoma cell 
lines [9J and cul tured human vascular endothelial cells [lOJ. 
The concent rations of r -IFN --y as well as t he temporal appear -
2 
FIG 1. Histogram of r-IF N--y- t.reated cul tured keratinocytes labe led 
wit.h anti -HLA-D R a nt ibody plus goat a nt imouse-FITC (top curve) or 
a cont rol immunoglobulin of I gG ~B isotype plus goat a ntirnouse-FITC 
(bo llom curve). T he vertical axis shows fraction ortota l cells (10-") per 
channel; the horizontal aX~5 shows flu orescence intensity in linear units . 
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ance of HLA-DR on the cultured cells are similar. However, by 
contrast to the other two cell types, in the keratinocyte cul tures 
t reated with r-IFN--y an HLA-DR-negative sUbpopulation (10-
30%) was always seen. T his could be due to very low staining 
intensity which cannot be distinguished ove r background con-
t rols using the FACS or may reflect a t rue subpopulation of 
cells which, for example, a re lacking t he receptor for r-IFN -')'. 
Considering t hat keratinocyte cul tures consist of cells in var-
ious stages of diffe rent iation, t he latte r explanation may be 
more plausible. 
Activated T lymphocytes produce -y- inte rferon, and there-
fo re, it is possible that these cells mediate HLA-DR expression 
by keratinocytes in vivo [7] . Alt hough our current work indi -
cates that r-IFN --y does not affect HLA-DR expression in LC, 
it is conceivable that, under certain disease conditions, LC shed 
HLA-DR in vivo and thereby coat neighboring kerat inocytes 
with this ant igen (T Basham, W Smith, L Lanier, V Morhenn, 
and T Merigan, submitted for publicat ion) . Whatever the exact 
mechanisms, it seems likely that -y- interferon plays an impor-
tant role in regulating keratinocyte HLA-DR expression in a 
variety of skin diseases where expression of HLA-DR may be 
necessa ry for both ant igen presentation and induction of cy-
to lytic T lymphocyte responses. 
We gra te full y acknowledge the expert technical assis ta nce of Ma rk 
Erickson a nd Eva A. Pfendt . 
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